A Better Understanding of Hodgkin Lymphoma through Research
The CRS stands out for its unwavering commitment to research, at a time when few organizations choose to dedicate all their efforts to it.
Both a hematologist and a researcher, Dr. Alina Gerrie is dedicated to studying chronic lymphocytic leukemia (CLL), the most common form of leukemia. With the support of a grant from the Cancer Research Society, she is currently leading a unique research project on a rare transformation: the evolution of CLL into Hodgkin lymphoma, a much more aggressive form of cancer.
“The CRS grant was essential in launching this CLL-specific research project, here in British Columbia. It helps us to better understand this biological phenomenon in order to achieve our ultimate goal: improving treatments.”
Dr.Gerrie’s dual role as a clinician-researcher allows her to be in direct contact with patients, discuss research with them, closely observe their concerns and identify their needs. Her interactions with patients are key to obtaining samples, building biobanks, and ultimately developing therapies that are better tailored to patients.
“The CRS funding has supported not only our lab activities but also our staff, without whom none of this would be possible. It’s due to this kind of support that research can truly move forward.”
80 Years of Supporting Research: A True Driving Force for Researchers
As the Cancer Research Society celebrates its 80th anniversary, Dr. Gerrie highlights the importance of its mission: to fund research on all types of cancer, which supports scientists and their research projects, to better prevent, detect, and treat the disease. She emphasizes that despite recent progress, much work remains to be done to better understand and treat cancer.
“The need for research remains monumental. Recent advances, such as discoveries in genomics, have transformed care. The CRS stands out for its unwavering commitment to research, at a time when few organizations choose to dedicate all their efforts to it.
I am deeply grateful that CRS donors believe in research as a means to improve the lives of people affected by cancer. Thanks to their support, we can truly advance care and improve survival rates for those living with the disease.”